China Biologic opens books on $297m follow-on
Nasdaq-listed China Biologic Products is marketing a sale of 2.5m American Depositary Shares (ADS) comprising a mix of new and existing shares, which could be worth $296.48m at its last close.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts